ASML HOLDING N.V. — INSTITUTIONAL TRADING PLAN

Date: July 10, 2026 | Spot: $1,804.25 | Your Cost: $135.00 | Position Size: 0.1% of capital Unrealized Gain: +1,236% (locked-in) | Beta: 1.39 | Market Cap: ~$695B

1. Trade Summary

What is the trade? This is a capital-preservation and tactical-trim decision on a deeply profitable legacy position, not an initiation question. You hold an ASML ADR position at $135 cost basis — acquired when the stock was a fraction of current levels — representing only 0.1% of total capital. The position is essentially "house money": the cost is so deeply underwater relative to current price that even a 50% drawdown from $1,804 produces a still-enormous gain.

Why does the opportunity exist? The opportunity is not a new entry opportunity — it is an exit-management opportunity. The stock sits exactly at the inflection where (a) parabolic blowoff top ($1,999.96 on June 30) has reversed with -10% in 8 sessions, (b) MACD death cross is confirmed (histogram at -$20.20, expanding bearish), (c) Q2 earnings on July 15, 2026 — exactly 5 calendar days / 3 trading days away — is a known binary catalyst with options pricing 50–65% IV (i.e., market implies a 10–20% move), and (d) July 17 monthly options expiration falls within 10 trading days (dealer gamma pin risk), with SK Hynix's $28B Nasdaq listing on July 18 (a related semi-supply-demand signal) also in that window.

What is the edge? The edge is recognizing that the investment thesis (EUV monopoly, AI capex compounding, multi-decade franchise) has been more than fully priced into the equity at 36.6x forward P/E and 61.1x trailing P/E — but the position-sizing edge is in the fact that 0.1% of capital at $135 cost is so small that any "trim" decision is purely a tactical gain-capture exercise, not a thesis-changing event. The macro environment (Iran/Hormuz energy shock, stagflationary impulse, 10Y at 4.56% with curve steepener pressure, Fed "family fight" framing, MATCH Act legislative overhang) is decisively bearish for high-multiple tech, even if bullish for the underlying secular AI buildout.

What is the market mispricing? The market is mispricing the joint probability of (a) MATCH Act passage in some form during 2026, (b) hyperscaler capex digestion in 2027, and (c) multiple compression to historical capital-equipment ranges. Probability-weighted fair value clusters around $1,500–$1,530 (per both bull and bear analyst fair value ranges), implying ~17% downside from spot. The market is treating the trade as "priced for perfection."

What matters most right now?

• Q2 2026 earnings on July 15 — within 5 trading days — is the dominant binary catalyst. Bernstein's $2,623 PT implies €48–52 FY27 EPS vs €43.24 consensus — an 11–20% above-consensus bar.
• July 17 monthly OPEX — within 7 trading days — creates dealer gamma dynamics that can amplify the earnings move.
• The position is so small (0.1%) that the dominant consideration is preservation of locked-in gains, not capital deployment.

Is this primarily:

• Sentiment-driven (primary): retail disengaged at ATH, crowded institutional long at peak multiple, peak euphoria signature
• Valuation-driven (secondary): 36.6x forward P/E with 2.6σ above 10-year mean
• Macro-driven (tertiary): stagflation + Iran/Hormuz + MATCH Act = asymmetric high-multiple compression risk
• Catalyst-driven (quaternary): Q2 earnings is the proximate trigger
• NOT momentum (failed breakout at $1,999.96, MACD bearish crossover)
• NOT mean-reversion in the constructive sense (no oversold signal — RSI 51.7, room to fall)

Recommended Trade Bias: Tactical Hold-to-Reduce / Take Partial Profits into Earnings Volatility

Rationale (analytical): The 0.1% position size is the dominant variable in this decision. At $135 cost, your position has compounded 13x — the locked-in gain is so large that even trimming 50% of the position (0.05% of capital) on a pre-earnings rally toward $1,830–$1,870 would generate an absolute P&L equal to a meaningful percentage of total capital while preserving optionality. The trade is not "should I buy more" — the trade is "how do I tactically protect a 13-bagger while maintaining convexity to the AI thesis." The technical setup (failed breakout + MACD death cross + RSI cooling from 63.8) confirms the short-term path of least resistance is down, with options market pricing 10–20% moves into earnings. A clean beat-and-raise could squeeze the stock back to $1,950–$2,000; an in-line print with cautious FY27 guide or High-NA margin commentary could trigger -10% to -15% to $1,575–$1,650. Given the cost basis is essentially irrelevant at this scale, the position should be sized for optionality preservation rather than thesis expression. A modest trim locks in 100%+ of original capital, while holding the core retains asymmetric long-duration upside on any AI-cycle re-acceleration. The combination of (i) peak multiple, (ii) confirmed bearish MACD, (iii) Q2 binary catalyst 5 days out, (iv) MATCH Act overhang, and (v) stagflationary macro argues for selling 30–50% of the position into a pre-earnings rally while retaining meaningful upside exposure. This is not an aggressive reduction — it is disciplined profit-taking on a small, deeply profitable position facing a known binary catalyst and stretched valuation.

2. Time Horizon Alignment

Setup classification: Short swing (3-week window) transitioning to medium-term tactical hold (3–6 months).

Expected move within timeframe:

• Immediate (5 trading days, through July 15 earnings): High-conviction 10–20% move is options-implied. The post-earnings window will determine whether the stock reclaims $1,900 (bullish) or breaks below $1,700 (bearish). Until then, expect dealer-gamma-driven compression toward the $1,800 strike with elevated intraday vol (ATR $94 = ~5.2% daily range).
• Near-term (1–6 months): Post-earnings trajectory depends on (a) Q2 print direction, (b) MATCH Act legislative calendar (Q3 2026 markup window), (c) hyperscaler Q2 capex guidance, (d) High-NA EUV shipment confirmations. Range-bound expectation: $1,500–$1,950 with directional bias post-earnings.

What could accelerate the thesis (upside):

• Q2 revenue >€9.0B vs €8.87B consensus with FY27 guide raised to €48+
• MATCH Act formally withdrawn or softened to symbolic scope
• High-NA EUV shipment to TSMC confirmed at €380M ASP
• Iran/Hormuz de-escalation → macro tailwind for high-multiple tech
• Sustained institutional buyback acceleration (€5.95B FY25 run-rate)

What could delay the thesis (downside):

• Q2 in-line or modest beat with cautious guide; no FY27 raise to €48+
• MATCH Act markup announcement (even without immediate passage) — 5–10% drawdown
• Hyperscaler capex digestion language in Q2 prints
• Failed technical support at $1,700 → algorithmic de-risking cascade
• Iran escalation re-imposing stagflationary impulse

Time horizon conclusion: The trade is multi-week, not multi-month. Q2 earnings on July 15 is the inflection; post-print, the setup transitions into MATCH Act monitoring mode and a re-evaluation of 2027 hyperscaler capex narrative. This is not a "hold through 2030" trade at $1,804 — it is a "tactically manage through the next 8 weeks" trade.

3. Market Structure & Positioning Analysis

Critical events inside the 5-day-before / 10-day-after window (per your prompt requirement):

Material event-driven flow analysis:

1. Q2 Earnings (Jul 15): This is the dominant binary. Options market is pricing 50–65% IV — i.e., a 10–20% move is being priced in. Dealer gamma positioning near the $1,800 strike creates pin risk: in the days leading into earnings, dealer hedging will compress price action toward $1,800 (where open interest is likely highest). On the print itself, gamma unwinds violently. Implication for your position: if you don't trim pre-earnings, the post-print move will be binary — clean beat-and-raise squeezes to $1,950+; in-line or cautious guide drops to $1,650–$1,700.

2. July 17 OPEX (5 trading days out): With ~$1,800 strike accumulation, dealers are likely short gamma. This means: into expiration, the stock is "magnetically held" near $1,800. Post-OPEX, the gamma pin releases and directional moves can accelerate. Combined with the Q2 print 2 days before OPEX, the setup is a textbook "earnings + OPEX" volatility explosion window.

3. SK Hynix $28B IPO (Jul 18): The IPO proceeds are earmarked for HBM and EUV-related capex. This is a demand-side validation signal for the AI capex cycle. Successful pricing (Hynix >$28B) is a soft bullish read for ASML; weak pricing is a bearish read. Position the catalyst 1 day after OPEX, so OPEX-driven volatility may obscure the read.

4. Hyperscaler Q2 prints (late July): Microsoft/Google/Meta/Amazon will report capex commentary. Any "digestion" language could be -5% to ASML (the chain effect: hyperscaler capex → TSMC EUV orders → ASML). This is the single most important secondary catalyst cluster for the trade.

Liquidity:

• Average daily volume 1.94M (~$3.5B notional)
• 10-day average: 2.2M
• Bid-ask spread tight in normal conditions; widens to 10–20 bps in volatile sessions
• Adequate liquidity for a 0.1% position (trivial market impact)

Institutional positioning:

• ASML is one of the most institutionally owned European listings
• Discretionary macro and AI-specialist pods are at peak conviction long
• Hedge fund net exposure to AI basket elevated (per macro report)
• Bernstein/Susquehanna/Jefferies top-of-distribution PTs ($2,623 / €2,350 / €1,560) — Bernstein's €2,623 implies €48–52 FY27 EPS vs €43.24 consensus (11–20% above-consensus bar)

Retail positioning:

• Reddit mentions DOWN 60.2% at ATH — textbook distribution signature
• Stocktwits sentiment DOWN 44.8% — disengagement at peak
• This is not euphoric retail — smart money has been distributing into passive flows while retail cooled

Options flow:

• Implied vol 50–65% into July 17 expiry (well above normal mid-20s)
• Skew is puts-bid (geopolitical fear premium)
• Gamma near $1,800 strike creates pin risk
• 0.43% short interest — no squeeze dynamics (negligible)
• Institutional hedging dominates; speculative options flow muted

Volatility conditions:

• ATR(14) = $94 = ~5.2% of price
• Realized vol 50%+ annualized
• Position sizing must be halved vs. a $50 ATR environment
• 2× ATR stops = $188 appropriate

Momentum conditions:

• 200 SMA = $1,332 (+35.4% above) → structural uptrend intact
• 50 SMA = $1,675 (+7.7% above, gap compressing fast)
• 10 EMA = $1,810 (price closed just below → short-term momentum flipped bearish)
• MACD line $30.82, signal $51.02 → death cross confirmed July 1
• MACD histogram -$20.20 (expanding bearish) → momentum accelerating bearish
• RSI(14) 51.67 (cooled from 63.8 on Jun 30, not yet oversold)
• Bollinger: upper $1,972, middle $1,836, lower $1,701
• June 30 intraday spike to $1,999.96 (above upper band) = textbook blowoff top

Is positioning crowded? YES — institutionally at peak conviction. Combined with retail disengagement at peak, this is a late-cycle distribution signature (per sentiment and research reports).

Is there squeeze potential? NO — short interest 0.43% of float (1.66M shares) is not squeezable. No gamma squeeze dynamics at this scale. The only way to a squeeze is a post-earnings dealer gamma unwind, which requires a clean beat-and-raise.

Is there unwind risk? YES — the 23–24 June KOSPI cascade demonstrated that crowded AI basket positioning is vulnerable to margin-driven de-grossing. Any macro shock or Q2 disappointment can trigger coordinated profit-taking.

Could liquidity amplify the move? YES on downside, more limited on upside. Buyback provides ~€15.87M/day passive bid (~$17M/day = ~0.5% of normal volume). On the upside, dealer short-gamma creates reinforcement; on the downside, dealer long-gamma creates amplification.

Are dealers likely to reinforce or suppress momentum? Pre-earnings (now through Jul 14): dealers are suppressive (pinning to $1,800). Post-earnings: dealers reinforce (gamma unwind). OPEX day (Jul 17): dealers are suppressive again (pinning). After OPEX: dealers are neutral until next catalyst.

Positioning State: Crowded Long / Late-Cycle Distribution

The combination of (a) peak institutional conviction, (b) retail disengagement at the top, (c) failed breakout, (d) MACD death cross, (e) blowoff-top signature, and (f) options market pricing 10–20% earnings moves is the textbook late-cycle setup. This is not "speculative mania" (no retail euphoria) and not "capitulation" (no panic), but it is the most vulnerable point in the cycle for a multiple compression event.

4. Catalyst Trading Framework

Immediate Catalysts (Days — within 5 trading days)

1. Q2 2026 Earnings (Jul 15) — DOMINANT. Options-implied 10–20% move. Bernstein-implied €48–52 FY27 EPS (vs €43 consensus) is the bar.
2. Dealer gamma positioning (Jul 10–14) — pinning to $1,800 into earnings. Vol compression until the print.
3. Pre-earnings positioning adjustments (Jul 10–14) — last opportunity to reposition before binary event.

Near-Term Catalysts (Weeks — within 10 trading days)

4. July 17 Monthly OPEX — dealer gamma expiration; pin release; vol expansion window.
5. SK Hynix $28B Nasdaq IPO (Jul 18) — direct demand-side validation signal for ASML's customer base.
6. TSMC Q2 Earnings (mid-late July) — capex guidance update; the most important secondary print.
7. Hyperscaler Q2 prints (Microsoft, Google, Meta, Amazon — late July) — capex digestion language risk.
8. Iran/Hormuz geopolitical developments — energy-led inflation re-acceleration; stagflation impulse.
9. MATCH Act legislative calendar (Q3 2026) — markup timing remains the dominant regulatory variable.
10. Lutnick/EUV investigation resolution — binary regulatory catalyst.

Medium-Term Catalysts (Months)

11. FY26 capex guidance from TSMC/Samsung/Intel (Q4 2026) — multi-year demand visibility.
12. High-NA EUV shipment to TSMC/Intel at scale — pricing power validation.
13. Service revenue disaggregation — annuity dynamics confirmation.
14. Buyback acceleration in FY26 — management conviction signal.
15. EU Chips Act 2.0 / Dutch industrial policy — strategic asset protection.

Most Important Catalyst

Q2 2026 Earnings on July 15, 2026

Why: This is the single binary event that determines the next 2–4 week trajectory. A clean beat-and-raise with FY27 guide raised to €48+ triggers a 10–15% squeeze back to $1,950+; an in-line print with cautious guide triggers -10% to -15% to $1,650–$1,700. The options market is pricing this as a 50–65% IV event (i.e., 10–20% move). Combined with dealer gamma pin to $1,800, this is a textbook volatility explosion window.

Catalyst That Could Invalidate the Trade

MATCH Act passage in current form (bipartisan ownership, Q3 2026 markup window) + Q2 earnings in-line + hyperscaler capex digestion language = triple-negative convergence that would trigger 25–40% drawdown to $1,200–$1,400. The combination is improbable but each component is a known tail risk within the 90-day window.

Catalyst That Could Trigger Violent Repricing

Lutnick/EUV investigation confirmation of an actual Wassenaar breach by ASML = $B+ fines + forced consent decree = 15–25% drawdown in single session. This is the most asymmetric single-event risk.

5. Trade Construction

Trade Setup: Trim 30–50% of Position into Pre-Earnings Strength; Hold Core

Position context: You hold ASML at $135 cost. Position is 0.1% of capital. Unrealized gain ~+1,236%. The position is so small and so deeply profitable that the dominant consideration is gain-capture and position-sizing, not thesis defense.

Ideal entry zones for trimming (not initiation):

For a 0.1% position, "entry" is conceptually a trim (selling into strength). The ideal trim zones are:

1. Primary trim zone: $1,830–$1,870 — resistance confluence zone. The 20 SMA / Bollinger middle band sits at $1,836. A rally to this zone on pre-earnings positioning (short-dated call buyers, gamma unwinds) creates the best trim opportunity. Trim 30% of position here.

2. Secondary trim zone: $1,890–$1,950 — if the stock can retest the 20 SMA and breach toward the Bollinger upper band ($1,972), this is a better trim for the "Bernstein squeeze" scenario. Trim additional 20% here (cumulative 50% trimmed).

3. Aggressive trim zone: $1,970+ — if the stock can re-approach the prior ATH of $1,999.96 on a pre-earnings momentum burst, this is the maximum trim level. Trim final 20% (cumulative 70% trimmed).

Add zone (only if trims executed):

• $1,575–$1,650 — 50 SMA at $1,675 zone. If earnings disappoint and the stock washes to this zone, add to the trimmed portion (not the full core). This is the institutional "add on weakness" zone.
• $1,500–$1,575 — April consolidation zone. If macro breaks and the stock flushes to this level, this is a deep value add for the core long-term thesis.

No-add zone:

• $1,700–$1,800 — current range, no edge, full of noise
• $1,900+ — chasing into a known binary catalyst is institutional malpractice at this multiple

Preferred Execution Style: Scale-In Trim on Strength, Event-Driven Decision on Print

The execution style for a trim is the inverse of initiation. You scale OUT as the stock rises into resistance. The pattern:

1. Today (Jul 10) through Jul 14: Set conditional sell orders at $1,830 / $1,890 / $1,970. Use limit-on-close or limit orders at the close. Avoid market orders in the 5-day pre-earnings window to minimize execution slippage against dealer-gamma pinning.

2. Jul 15 (Earnings day): Hold the trimmed-and-remaining position through the print. DO NOT trade the print unless you have a clear pre-committed plan. The options market is pricing 10–20% moves; the spread of outcomes is too wide for discretionary trading.

3. Post-print (Jul 16+): Reassess. If clean beat-and-raise to €48+: add back the trimmed portion on the gamma squeeze (likely $1,900+). If in-line/cautious: do nothing, hold core, wait for stabilization. If miss/bad guide: do not panic-sell; let the wash complete toward $1,650; reassess add opportunity.

Why this execution style:

• The 0.1% position size means the absolute gain/loss from execution precision is trivial (a few hundred dollars on $X00,000 of capital)
• The dominant variable is whether to trim, not at what exact price
• Conditional limit orders eliminate emotional decision-making in a binary window
• Holding the trimmed-but-remaining position preserves the optionality value of the AI thesis

Entry/Exit Framework for the Trim Decision

6. Risk/Reward Analysis

Expected Upside (12-month base case)

Target: $1,950–$2,050 (forward P/E 32–34x on FY27 consensus €43)

• Probability: 25%
• Return from $1,804: +8% to +14%
• Catalysts: Q2 beat-and-raise, MATCH Act softened, hyperscaler capex sustained, High-NA shipment confirmation

Expected Downside (12-month base case)

Target: $1,450–$1,550 (forward P/E 26–28x on cyclical digestion, FY27 €39–40)

• Probability: 30%
• Return from $1,804: -14% to -20%
• Catalysts: Q2 in-line with cautious guide, MATCH Act progress, hyperscaler capex digestion language, multiple compression to capital-equipment mean

Risk/Reward Ratio

Asymmetric to the downside: ~1:1.5 to 1:2 at current valuation. The bull case requires multiple positive surprises; the bear case requires only one negative surprise (earnings OR MATCH OR capex) to trigger meaningful drawdown. At 0.1% position size, the absolute dollar R/R is favorable regardless of direction (cost basis is so far below market that the position is "house money").

Scenario Analysis

Base Case (35% probability): $1,500–$1,650

• Q2 print in-line with consensus (€8.87B revenue, 52.8% GM)
• FY27 guide raised modestly to €44–45 (not the €48+ Bernstein bar)
• Multiple compresses to 28–32x on earnings miss-vs-Bernstein
• MATCH Act progress in Q3 2026 adds 5–8% compression
• Hyperscaler capex digestion language in late-July prints
• Path: Drift down to $1,700, wash to $1,575 on July 17 OPEX gamma release, consolidate $1,500–$1,650 through Q3

Bull Case (25% probability): $2,200–$2,500

• Q2 clean beat-and-raise: revenue >€9.0B, FY27 guide >€48
• High-NA EUV shipment to TSMC at €380M ASP confirmed
• MATCH Act formally withdrawn or water-downed to symbolic scope
• Hyperscaler capex guidance raised
• Iran/Hormuz de-escalation
• Path: Post-earnings squeeze to $1,950, OPEX gamma unwind adds $100–150, then drift to $2,200–$2,500 on Q3 capex news

Bear Case (25% probability): $1,000–$1,200

• Q2 print in-line or modest miss, no FY27 raise
• MATCH Act passes in current form
• Hyperscaler capex digestion language triggers TSMC EUV order moderation
• Multiple compresses to 18–22x on combined policy + cycle
• Path: Post-earnings drop to $1,700, MATCH markup -10% to $1,530, late-summer consolidation $1,000–$1,200

Tail-Risk Scenario (15% probability): $700–$900

• Q2 misses OR Lutnick investigation confirms EUV breach
• MATCH Act current-form passage
• Iran escalation re-imposes stagflation
• TSMC/Taiwan geopolitical incident (kinetic or quarantine)
• Combined policy + cycle + geopolitical shock
• Path: -25% to -40% from current over 2–4 weeks; "buy the dip" thesis breaks

Trade Quality Score: 3/10 (for initiation); 7/10 (for management of existing position)

For initiation at $1,804: Score is 3/10 — extremely poor. This is a stretched multiple on a stock facing a known binary catalyst with crowded positioning and a macro tailwind headwind. No new capital should be deployed here.

For management of the 0.1% legacy position at $135 cost: Score is 7/10 — favorable. The cost basis is so far below market that any rational action (hold, trim, or fully exit) is materially accretive vs. the original $135 risk. The dominant variable is tactical optimization of an already-locked-in gain.

7. Entry & Exit Plan

Primary Entry Zone (for any new capital, if you change your mind and want to add)

NOT RECOMMENDED. The trade setup does not support initiation. If you must add:

• $1,575–$1,650 (50 SMA / lower Bollinger Band zone) — only on confirmed post-earnings stabilization with technical reversal
• $1,500–$1,575 (April consolidation zone) — only on macro sell-off unrelated to fundamentals

Secondary Entry Zone

• $1,400–$1,500 — only on a true macro/regime change (e.g., stagflation recession, Iran escalation, MATCH passage) AND technical capitulation
• $1,200–$1,300 — only on a Taiwan-related tail event; this would be a generational entry but implies a thesis break

Add Zone (for trimmed portion, if executed)

• $1,650–$1,700 post-earnings if Q2 in-line but stock washed; RSI <40; volume climax
• $1,575–$1,650 post-earnings if Q2 miss and stock continues to fall; MACD histogram turns; volume climax

Profit-Taking Levels (Trim Plan)

• $1,830–$1,870: Trim 30% of original position
• $1,890–$1,950: Trim additional 20% (cumulative 50%)
• $1,970+: Trim final 20% (cumulative 70%)

Full Exit Levels

• Post-earnings clean beat-and-raise to $1,950+: Trim 50–70%; retain 30–50% as core long-term
• Post-earnings in-line: Hold full position
• Post-earnings miss: Hold full position; do not panic-sell into volatility
• MATCH Act markup in Q3 2026: Reduce remaining position by 50% on first announcement; reassess
• Lutnick investigation confirms breach: Exit remaining position immediately

Thesis Invalidation Level

Decisive close below $1,500 on elevated volume AND:

• FY27 EPS consensus reduced to <€40
• MATCH Act passes in current form
• Hyperscaler capex cuts confirmed in Q3 prints
• Taiwan Strait kinetic/quarantine incident

At this level, the AI capex thesis is broken. Even at $135 cost, the position would still be up significantly, but the optionality of further compounding is gone. Full exit at $1,500 if all three conditions align.

Price Action Confirmation Framework

Confirms the bull thesis (hold/add):

• Price reclaims 10 EMA ($1,810) for 2+ consecutive sessions
• MACD histogram stops deepening (forms a base)
• RSI hooks up from 40–45 zone
• Volume expands on up days, contracts on down days
• Q2 print: revenue >€9.0B, FY27 guide >€48, High-NA commentary constructive

Weakens the bull thesis (trim):

• Price rejects 10 EMA ($1,810) multiple times
• MACD histogram continues to deepen below -$25
• RSI breaks below 45
• Bollinger lower band ($1,700) breaks on close
• Q2 print: in-line or below consensus, no FY27 raise, cautious High-NA commentary

Invalidates the trade entirely (exit):

• Decisive close below $1,500 on volume >2.5M
• MATCH Act passes in current form with $1B+ fines attached
• Lutnick investigation confirms EUV breach
• Taiwan Strait kinetic incident
• Q2 misses consensus by >3% on revenue AND/OR gross margin contracts >100bps sequentially

8. Risk Management Framework

Maximum Position Sizing Guidance

Current: 0.1% of capital — appropriate.

• Should NOT exceed 1% of capital at any valuation above $1,500 (multiple is too rich)
• Could go to 2% of capital only on a flush below $1,400 (deep value zone, with thesis confirmation)
• Maximum 3% of capital is reserved for a true macro dislocation (Taiwan, MATCH passage, AI winter) where the long-term thesis becomes a deep-value opportunity

Stop-Loss Logic

• For the existing 0.1% position: NO HARD STOP. The cost basis ($135) is so far below market that any drawdown is still profitable. A hard stop is institutionally inappropriate here.
• For any ADD (if you add on weakness): Stop below $1,400 (~22% from current), or $1,200 if you size for deeper drawdown tolerance.
• Volatility-adjusted exposure: With ATR $94, the 2× ATR stop is $188. A close below $1,616 (current - 2× ATR) on volume >2.5M would be a technical sell signal.

Volatility-Adjusted Exposure

• ATR $94 = 5.2% of price
• Annualized realized vol ~50%
• Implied vol 50–65% into earnings
• Position sizing math: A 0.1% position with 50% vol contributes 0.05% of capital in 1σ daily move — negligible. Even a 3-sigma event (5% daily) on a 0.1% position is 0.15% of capital. Position size is appropriately scaled for current vol regime.

Hedging Ideas

1. Protective put (Aug or Sep $1,700 strike, ~$30-50 cost per share): Insurance against post-earnings downside. Cost ~0.3% of position value. Worth it given the binary catalyst.
2. Collar (sell Aug $2,000 call / buy Aug $1,700 put): Financed hedge. Caps upside but protects against >6% drawdown.
3. Pair trade: Long ASML / Short SMH (semiconductor ETF): Expresses the relative value view; reduces beta.
4. Long QQQ puts / long GLD (gold): Macro hedge against stagflationary impulse + AI capex digestion.

Correlation Risks

• High correlation to SMH (semiconductor ETF) and QQQ (Nasdaq): Beta 1.39 vs S&P, but ~1.5 vs tech-heavy baskets
• High correlation to AI narrative stocks (NVDA, AVGO, TSM): Magnitude of correlation increases in stress regimes
• Negative correlation to USD (DXY): EUR-reporting company; weak dollar = positive ADR translation
• Negative correlation to oil/energy (Iran/Hormuz regime): Energy spike = stagflation = high-multiple tech compression

Event Risk Management

Q2 Earnings (Jul 15):

• Pre-event: Trim 30% into $1,830–$1,870; consider protective put
• Post-event: Hold core; add back 30–50% of trim on confirmed beat-and-raise
• Avoid: Trading the print itself; market orders during the print; leverage

July 17 OPEX:

• Pre-OPEX: Pin risk keeps stock near $1,800; do not chase
• OPEX day: Expect range expansion; let pin release
• Post-OPEX: Reassess; directional move can accelerate

MATCH Act (Q3 2026):

• Pre-markup: Monitor legislative calendar; reduce exposure 25% on first credible report of markup scheduling
• On passage in current form: Tactical exit 50% of remaining
• On passage in softened form: Hold; the news removes geopolitical discount

Lutnick Investigation:

• On confirmation of breach: Full exit
• On ASML exoneration: Hold; the news removes regulatory overhang

Overnight Risk Considerations

• ASML ADR is USD-denominated but EUR-reporting — overnight FX risk is real but small
• Macro news flow (Iran, Fed, geopolitical) can gap the stock overnight
• Pre-earnings, overnight risk is elevated: consider closing any open options positions or using limit orders to manage gap risk
• The 0.1% position size is small enough that overnight gap risk is institutionally negligible

Biggest Hidden Risk

The joint probability of (a) MATCH Act passage in some form, (b) hyperscaler capex digestion in 2027, and (c) multiple compression to historical capital-equipment ranges. These are independent events, each with 30–50% probability; the joint probability is meaningful. The market is treating them as separate tail risks; the correct framework treats the joint outcome as a base-case tail.

The bear thesis is not that ASML is a bad company. The bear thesis is that ASML is a great company in a temporarily over-owned equity at peak multiple, facing a stagflationary impulse and an active legislative threat to 15–20% of its revenue.

Could Liquidity Disappear Suddenly?

YES in stress. The 23–24 June KOSPI cascade demonstrated that crowded AI positioning can produce 5–7% single-session moves on marginal news. Liquidity is adequate in normal conditions (1.94M ADV, ~$3.5B notional) but thins in stress. The position is small enough that liquidity is not a binding constraint, but the principle applies: in stress, exit is at worse prices.

Could This Become a Crowded Trap?

YES — already is. The combination of peak institutional positioning + retail disengagement + failed breakout + binary catalyst is the textbook late-cycle trap. A crowded long at peak multiple is a vulnerable position, not a strong one. This is why the trim recommendation is so important.

Could Macro Override the Company Thesis?

YES — and is doing so now. The Iran/Hormuz energy shock + stagflationary impulse + Fed "family fight" framing is a headwind to high-multiple tech, even as the underlying AI thesis remains intact. This is the most important framing: the AI thesis is fine; the equity is not. Macro can and does override the company thesis in the short to medium term.

Recommended Risk Posture: Moderate-to-Defensive

Why moderate-to-defensive rather than aggressive:

• The position is small (0.1%) — there is no need to be aggressive
• The cost basis is so favorable that any defensive action is already locked in
• The macro and regulatory environment is asymmetric to the downside
• The technical setup confirms short-term weakness
• The binary catalyst (earnings) is 5 trading days away

Conservative elements:

• Trim 30–50% pre-earnings
• Consider protective put if size permits
• Avoid leverage
• No new capital deployment above $1,500

Aggressive elements:

• Retain 30–50% of original position for post-earnings volatility
• Add back on confirmed weakness below $1,650
• Hold 3–5 year horizon on remaining core

9. Technical & Behavioral Confirmation

Trend Structure

• Long-term (200 SMA = $1,332): Price +35.4% above → structural uptrend intact
• Medium-term (50 SMA = $1,675): Price +7.7% above, gap compressing fast → medium-term weakening
• Short-term (10 EMA = $1,810): Price closed just below on Jul 9 → short-term momentum bearish

Support/Resistance Levels (Consolidated)

Volume Behavior

• Recent volume profile (Jun 24–Jul 9):
• Jun 23: 2.42M (sell day)
• Jun 24: 2.03M
• Jun 25: 2.20M
• Jun 26: 2.84M (high volume on down day → distribution)
• Jun 29: 1.76M
• Jun 30: 2.71M (ATH day, high volume → blowoff)
• Jul 1: 2.58M
• Jul 2: 2.70M (sell day, high volume → continued distribution)
• Jul 6: 1.95M
• Jul 7: 1.86M
• Jul 8: 1.42M (low volume — indecision)
• Jul 9: 1.54M
• Pattern: High volume on down days and on ATH = institutional distribution. Low volume on recent up days = no real accumulation. This is a classic distribution volume signature.

Momentum Characteristics

• MACD: $30.82 line, $51.02 signal, -$20.20 histogram (expanding bearish) → momentum confirmed bearish
• RSI(14): 51.7 (cooled from 63.8 on Jun 30) → cooling but not oversold (room to fall)
• Bollinger: Upper $1,972, middle $1,836, lower $1,701 → bands expanding, lower band at $1,701 within reach
• ATR: $94 (~5.2% of price) → elevated vol, position sizing halved

Volatility Compression/Expansion

• Current state: Compression (pre-earnings dealer gamma pinning)
• Imminent: Expansion (earnings + OPEX catalyst cluster)
• Post-event: Re-compression or new trend, depending on print direction

Breakout Probability

• Upside breakout above $2,000: Low probability (~15%) without Q2 beat-and-raise + multiple positive catalysts
• Downside breakdown below $1,700: Moderate probability (~35%) given MACD death cross + blowoff top + distribution volume
• Range-bound $1,700–$1,900: Most likely (~50%) absent catalyst resolution

Exhaustion Risk

HIGH. The combination of (a) blowoff top on Jun 30, (b) MACD death cross, (c) RSI cooling from overbought (63.8 → 51.7), (d) failed breakout, (e) distribution volume, (f) options market pricing 10–20% earnings move = exhaustion confirmed.

Reflexivity Dynamics

• Bull reflexivity loop: Strong Q2 print → Bernstein-style PT upgrades → passive inflows → price rise → "proof" of thesis → further upgrades
• Bear reflexivity loop: Disappointing Q2 print → algorithmic de-risking → price fall → margin calls → further selling
• Current state: Bear loop is in early stages (one leg down from ATH). The Q2 print will determine which loop activates.

Is Price Action Confirming Fundamentals?

NO — at current multiple (36.6x forward P/E), the price is well above what fundamentals support. The price is confirming narrative, not fundamentals. The fundamentals (19.2% EPS growth, EUV monopoly) are exceptional; the equity is detached from those fundamentals by ~20% on any reasonable DCF.

Is Momentum Healthy or Overheated?

HEALTHY AT THE 200 SMA LEVEL (long-term trend intact) but OVERHEATED AT THE RECENT PEAK (blowoff top, distribution volume). The cooling phase from Jun 30 peak is healthy in the context of digestion, but the technical posture is now bearish short-term and neutral long-term.

Are Buyers Becoming Exhausted?

YES. The volume signature shows buyers stepped in on Jun 30 (ATH) and were immediately overwhelmed by sellers on Jul 1–2. Buyers have not been able to push price back above the 10 EMA ($1,810) on any session since. Buyer exhaustion is confirmed.

Is There Evidence of Institutional Accumulation/Distribution?

DISTRIBUTION — clear and consistent with the late-cycle signature:

• Reddit mentions DOWN 60.2% at ATH → retail disengagement
• Stocktwits DOWN 44.8% at ATH → retail disengagement
• Sell-side target concentration at top of distribution (Bernstein $2,623)
• Volume signature: high on down days, low on up days
• KOSPI cascade (Jun 23–24) tested and held above $1,700 → bounce, but no follow-through buying
• Buyback at €15.87M/day = ~$17M = ~0.5% of normal volume → passive bid, not aggressive accumulation

Technical Condition: Distribution / Weakening

The technical picture is one of distribution inside a structural uptrend:

• The 200 SMA confirms the secular uptrend is intact
• The 50 SMA is being tested as price compresses toward it
• The 10 EMA has flipped to resistance
• MACD has confirmed a death cross
• Volume signature shows distribution
• Options market is pricing expansion

This is not "breakdown risk" yet (price is still above the 50 SMA at $1,675) but it is a "weakening" condition that precedes breakdown by days to weeks, with the Q2 earnings print as the proximate trigger.

10. Options & Volatility Strategy

Implied Volatility

• Current IV: 50–65% into July 17 expiry (per research reports and options market)
• Historical norm for ASML: mid-20s
• IV is significantly elevated → options are expensive; sell-premium strategies have favorable vol; buy-premium strategies have unfavorable vol

Skew

• Puts bid vs calls — geopolitical fear premium
• Implies market is pricing more downside tail risk than upside surprise
• Consistent with the post-blowoff-top technical posture

Gamma Exposure

• Dealers are short gamma near $1,800 (per research reports)
• This creates the pin risk into July 17 OPEX
• Post-earnings, gamma unwinds can amplify directional moves

Earnings Volatility Pricing

• IV 50–65% implies expected move of 10–20% in either direction
• Historical ASML earnings moves: typically 5–10%
• Current IV is pricing a larger-than-typical earnings move, consistent with peak multiple + binary catalyst + crowded positioning

Dealer Positioning

• Dealers are short gamma at $1,800 strike (inferred from call open interest concentration)
• Pre-earnings: dealers will hedge by buying stock on weakness, selling on strength → pin risk suppresses volatility
• Post-earnings: gamma unwinds → volatility expands in direction of move

Options Liquidity

• ASML has deep options liquidity (mega-cap)
• Bid-ask spreads tight on near-the-money strikes
• Sufficient to execute complex multi-leg strategies

Are Options Attractive?

DEPENDS ON DIRECTION:

• For the trim-protection hedge: YES — buy Aug $1,700 put as portfolio insurance (cost ~3–5% of position)
• For directional bets: Mixed — vol is rich, so buying options is expensive, but the binary nature of the catalyst supports selling premium
• For relative-value: Long ASML puts / short SMH puts (or short ASML calls / long XLE calls) — express the macro view without taking full directional exposure

Is Volatility Overpriced or Underpriced?

OVERPRICED at 50–65% IV (vs. mid-20s norm) — but appropriately so given the binary catalyst and macro overhang. Vol is correctly pricing the event risk; it is not mispriced in the typical sense. The implication: selling premium (e.g., covered calls) is favorable; buying premium is expensive.

Asymmetry in Calls vs Puts?

• Calls: Expensive (IV rich, but rally is constrained by 36.6x multiple + macro)
• Puts: Expensive (IV rich, but downside is real with MATCH/capex/macro risks)
• Net: Both wings are expensive; vol-selling (e.g., iron condors, strangles) is favored over vol-buying in a vacuum

Preferred Structure: Protective Put for Trim Insurance + Optional Covered Call on Retained Core

For a 0.1% position, the cleanest options strategy is:

1. Protective Put (Aug $1,700 strike, ~$50–60 per contract): Insurance against post-earnings downside. Cost ~3% of position value. Protects against >5% drawdown. This is institutional risk management, not speculation.

2. Covered Call (Aug $1,900 call, sell for ~$30–40): If you retain the core position post-trim, selling an upside call captures some of the elevated IV. Caps your upside but generates premium income. Net effect: convert a small portion of the position into a yield-generating structure.

3. Collar (sell Aug $1,950 call, buy Aug $1,700 put): Zero-cost or low-cost collar. Defines the exit zone. Good for the core retained position.

4. Pair Trade with Options (long ASML Aug $1,500 put / short SMH Aug $1,500 put): Express the relative-value view. ASML has more downside on a multiple compression event than SMH (which is more diversified).

For a 0.1% position, the most efficient hedge is the protective put on the retained position (post-trim). Cost is trivial (~$30–60 per 100 shares), protection is meaningful (caps drawdown at 5–7%), and the structure is institutional.

Why This Structure

• Position is small (0.1%) — options strategies need to be cost-efficient
• Vol is elevated — protective put is expensive but appropriate for a known binary catalyst
• The position is highly profitable — the cost of insurance (3% of position) is small relative to the locked-in gain
• The trade is asymmetric to the downside — protective put is the cleanest way to define the downside

11. Institutional Trading Interpretation

Would Hedge Funds Chase This Move?

PARTIALLY — on the upside, yes; on the downside, no. Hedge funds are already long at peak conviction. The marginal buyer is retail + systematic (passive flows). Elite funds (Tiger Cub, Citadel, Millennium, etc.) are more likely to trim on the Q2 print than to add, regardless of direction. A clean beat-and-raise might trigger tactical short-covering (which amplifies the squeeze), but the structural posture is to take profit, not add.

Would Institutions Buy Weakness?

YES — below $1,650. Sovereign wealth funds (Temasek, GIC, NBIM), pension funds, and long-only tech specialists all view ASML as a strategic core holding. Below the 50 SMA ($1,675) and especially below $1,575, institutional "add on weakness" flows become meaningful. This is why I recommend not panic-selling into post-earnings weakness — the bid is real below $1,650.

Could Fast Money Reverse Aggressively?

YES — both directions. Fast money (systematic, quant, HFT) trades off the MACD death cross, the RSI break, and the 50 SMA test. A break of $1,675 with volume would trigger systematic de-risking, producing 5–10% in days. Conversely, a post-earnings squeeze to $1,900 would trigger systematic covering, producing 5–10% in hours.

Is There Potential for Reflexive Upside/Downside?

YES — both directions, asymmetric to the downside:

• Upside reflexivity: Post-earnings beat-and-raise + gamma squeeze + Bernstein-style PT upgrade = 10–15% move in days
• Downside reflexivity: In-line print + algorithmic de-risking + MATCH markup news + margin cascade = 15–20% move in days
• Asymmetry: Downside moves are larger because (a) vol is already elevated, (b) put bids are already wide, (c) dealer gamma on the downside is more reactive

Is This Suitable for Concentrated Exposure?

NO — at current multiple and with current binary risk, this is not a concentrated position. The trade is appropriate as a 2–5% portfolio weight (in a tech/AI mandate) or as a 0.1–1% portfolio weight (in a diversified portfolio). At 0.1%, the position is appropriately sized.

Institutional Trading Character

Hedge Candidate / Cyclical Opportunity to TRIM (downgraded from "Core Long-Term Holding")

• NOT a "High Conviction Institutional Long" at $1,804 — too rich, too crowded, too binary
• NOT "Tactical Momentum Trade" — momentum has flipped
• NOT "Crowded Narrative Trade" — the narrative is now exhausted at the price level
• NOT "Volatile Speculation" — the underlying business is exceptional
• NOT "Mean Reversion Setup" in the constructive sense — there's no oversold signal
• NOT "Fragile Momentum" — the trend is up, but the recent move is fragile
• IS "Distribution Candidate" — the late-cycle distribution signature is clear

The right institutional role: Hedge candidate / Cyclical opportunity to trim. This is a position-management trade, not a thesis-expression trade.

12. Final Trading Plan

1. What is the trade?

A tactical trim of 30–50% of the existing 0.1% ASML position into pre-earnings strength, with conditional add-back on confirmed post-earnings weakness, and a protective put on the retained core to define downside risk.

2. Why does the opportunity exist?

The opportunity is a tactical gain-capture window on a deeply profitable legacy position (cost $135, +1,236% unrealized) facing a known binary catalyst (Q2 earnings July 15) at peak multiple (36.6x forward P/E) with crowded institutional positioning and a stagflationary macro impulse.

3. What is the highest-probability outcome?

Base case (35% probability): Q2 in-line print with no FY27 raise to €48+; multiple compresses to 30–32x; stock drifts to $1,500–$1,650 over 8–12 weeks as MATCH Act progress and hyperscaler capex digestion language compound the multiple compression.

Trim plan captures gains in the bull case (25% probability: rally to $1,900+ on beat-and-raise) and limits damage in the bear case (25% probability: drop to $1,000–$1,200 on combined cycle + policy shock).

4. What is the expected catalyst path?

• Pre-earnings (Jul 10–14): Dealer-gamma compression toward $1,800. Trim into $1,830–$1,870 if reached.
• Earnings (Jul 15): Binary print. In-line with no FY27 raise = drift to $1,650–$1,700. Beat-and-raise to €48+ = squeeze to $1,900+.
• OPEX (Jul 17): Gamma pin release. Volatility expansion.
• Hyperscaler prints (late July): Capex digestion language risk.
• MATCH Act (Q3 2026): Legislative calendar — markup timing is the dominant regulatory variable.
• Macro: Iran/Hormuz de-escalation removes stagflationary overhang; escalation deepens it.

5. What are the key entry levels?

For the trim (selling into strength):

• Primary: $1,830–$1,870 (20 SMA / Bollinger middle band)
• Secondary: $1,890–$1,950 (Bollinger upper band)
• Aggressive: $1,970+ (near-ATH)

For adding back (if trims executed):

• $1,575–$1,650 (50 SMA / lower Bollinger Band)
• $1,500–$1,575 (April consolidation zone)

For new capital (NOT RECOMMENDED):

• $1,200–$1,500 — only on macro dislocation

6. What are the key risk factors?

• Q2 print miss or cautious guide — 10–15% drawdown to $1,575–$1,650
• MATCH Act passage in current form — 15–25% drawdown on top of earnings reaction
• Lutnick investigation confirmation — 15–25% in single session
• Taiwan Strait kinetic incident — 20–30% in days
• Hyperscaler capex digestion — 5–10% incremental drawdown
• Stagflationary macro impulse (Iran/Hormuz re-escalation) — sector-wide high-multiple compression

7. What invalidates the trade entirely?

The bull thesis (hold core) is invalidated by:

• Decisive close below $1,500 on volume >2.5M
• FY27 EPS consensus reduced to <€40 (from current €43.24)
• MATCH Act passes in current form
• Hyperscaler capex cuts confirmed in Q3 prints
• Taiwan Strait kinetic/quarantine incident
• Lutnick investigation confirms EUV breach

At this point, full exit of remaining position. The cost basis still produces a massive gain, but the optionality of further compounding is gone.

8. What should traders monitor DAILY?

1. ASML price action — watch for trim-level hits ($1,830, $1,890, $1,970)
2. MACD histogram — watch for stabilization or further deepening
3. RSI(14) — watch for break of 50 (bearish) or 40 (capitulation)
4. 10 EMA ($1,810) — watch for reclaim (bullish) or rejection (bearish)
5. Volume profile — watch for distribution continuation or accumulation emergence
6. Hyperscaler pre-earnings commentary — capex language from MSFT/GOOGL/META/AMZN
7. MATCH Act legislative calendar — markup scheduling signals
8. Iran/Hormuz developments — energy/transport risk premium
9. FOMC commentary — rate path implications
10. VIX and dealer gamma — vol regime signal

Final Trade Recommendation

Tactical Hold-to-Reduce

For existing holders at $135 cost: Trim 30–50% into pre-earnings strength ($1,830–$1,890); retain 30–50% as core; consider Aug $1,700 protective put on retained core (~$50/contract); do NOT initiate new capital above $1,500.

For new capital at $1,804: No initiation. The setup does not support new entry at this multiple and with this binary catalyst. If a flush to $1,200–$1,500 occurs on combined earnings miss + MATCH news, that becomes a deep-value entry for a 3–5 year horizon, but that's a future trade, not the current trade.

Conviction Level: Medium-High on Trim Plan; Low on Directional Conviction Post-Earnings

The trim plan is high-conviction because it captures gains in a binary window with limited downside (cost basis is $135). The directional conviction post-earnings is low because the joint distribution of outcomes is wide; the trade is not a directional bet but a position-sizing bet.

Risk/Reward Profile: Unattractive at $1,804 for Initiation; Attractive Above $1,820 for Trim; Asymmetric to Downside

Expected Volatility: High (50%+ annualized; ATR 5.2% of price)

Trade Time Horizon: Short Swing (1–4 weeks) for the Trim; Medium-Term Hold (3–6 months) for Retained Core

Execution Urgency: Moderate — the trim should be executed on the next 1–2 sessions of strength; do not rush, but do not delay into the earnings window

Step-by-Step Execution Checklist for Traders

Pre-Earnings Window (Jul 10–14, 4 trading days)

Day 1 (Jul 10, Today):

• [ ] Set conditional limit sell orders at $1,830 / $1,890 / $1,970 (30% / 20% / 20% of position)
• [ ] Set GTC (Good 'Til Canceled) orders to avoid having to monitor intraday
• [ ] Calculate position cost basis: 0.1% of capital × your total capital = dollar value of position
• [ ] Calculate 30%/50%/70% trim sizes in dollars and shares
• [ ] Assess whether to buy protective puts: Aug $1,700 strike, current price ~$50/contract
• [ ] If buying puts, limit size to $X00–$Y00 (do not exceed 5% of position value in hedge cost)
• [ ] Check VIX (current ~16, 5th percentile of 52-wk range) and dealer gamma positioning
• [ ] Confirm 50 SMA level ($1,675) and 200 SMA level ($1,332) for reference

Days 2–4 (Jul 11–14):

• [ ] Monitor daily price action against 10 EMA ($1,810) and 20 SMA ($1,836)
• [ ] Track MACD histogram: stabilization = bull, further deepening = bear
• [ ] Track RSI(14): break below 50 = caution; break below 40 = add zone approaching
• [ ] Watch for pre-earnings analyst commentary (any pre-print upgrades/downgrades)
• [ ] Monitor hyperscaler pre-earnings capex commentary (MSFT/GOOGL/META/AMZN)
• [ ] Watch for any Iran/Hormuz geopolitical developments
• [ ] Watch for any MATCH Act legislative signals
• [ ] Do NOT chase any rally above $1,890 — let limit orders work

Earnings Day (Jul 15):

• [ ] Do NOT trade the print itself
• [ ] If you have limit orders, they should already be resting at trim levels
• [ ] Hold position through the print regardless of direction
• [ ] After the print, assess:
• [ ] Revenue vs €8.87B consensus
• [ ] Gross margin vs 52.8% prior
• [ ] FY27 guide (key bar: €48+)
• [ ] High-NA EUV commentary
• [ ] China revenue commentary
• [ ] Q3 revenue guide

Post-Earnings Decision Tree:

• [ ] IF clean beat-and-raise to €48+: Add back 30–50% of trimmed position on gamma squeeze (likely $1,900+)
• [ ] IF in-line, no FY27 raise: Hold; do nothing; wait for stabilization
• [ ] IF miss OR guide down: Do NOT panic-sell; wait for wash to $1,650; reassess

OPEX Day (Jul 17):

• [ ] Expect range expansion as gamma pin releases
• [ ] Do NOT chase intraday moves
• [ ] Assess: did the post-earnings trend establish? Or is the stock in no-man's-land?

Late July / Early August (Hyperscaler Prints Window):

• [ ] Monitor Microsoft/Google/Meta/Amazon capex commentary
• [ ] If "digestion" language appears, prepare for incremental drawdown
• [ ] Consider additional trim if remaining position is still 50%+ of original
• [ ] Watch TSMC capex guidance (most important data point)

Q3 2026 (MATCH Act Window):

• [ ] Monitor legislative calendar
• [ ] If MATCH Act markup scheduled: prepare for tactical exit
• [ ] If MATCH Act passes in current form: exit 50% of remaining position
• [ ] If MATCH Act passes in softened form: hold (news removes overhang)
• [ ] If MATCH Act formally withdrawn: add (re-rating catalyst)

Q4 2026 (Reassessment Point):

• [ ] Reassess core position based on year-to-date performance
• [ ] If thesis intact and price at deep value: add to original 0.1% sizing
• [ ] If thesis broken: full exit of remaining position

Closing Notes

The single most important takeaway: This is a position-management trade, not a thesis trade. Your cost basis ($135) is so far below current market ($1,804) that you are playing with house money. The trim plan captures gains, limits downside, and preserves optionality on the AI thesis. No new capital should be deployed at current levels. The asymmetric risk-reward favors tactical optimization of the existing position over directional conviction on the post-earnings path.

The single most important monitoring point: Q2 earnings on July 15. Everything else is secondary. The single most important pre-earnings action: Set trim levels now and let them work. Do not over-manage in the pre-earnings window.

The single most important pre-existing condition: The position is 0.1% of capital. The cost basis is $135. The position is so small and so profitable that the cost of the trim plan (potential forgone upside if the stock squeezes to $2,500) is trivially small relative to the locked-in gain. The trim is a no-brainer for a position of this size at this cost basis with this binary catalyst ahead. Execute it.

The single most important ongoing discipline: Do NOT add to this position at any price above $1,500. The thesis is intact at the business level, but the equity is detached from the fundamentals by ~20% on any reasonable DCF. Wait for the multiple to compress before adding capital. The most likely path to that compression is the next 8–12 weeks.

This is institutional-style research and does not constitute investment advice. All forecasts are probabilistic. Position sizing should reflect conviction, mandate constraints, and overall portfolio construction. The cost basis of $135 in the user's position is exceptionally favorable, and the trade recommendations should be evaluated in the context of the user's specific portfolio and tax situation.